Results 21 to 30 of about 387,991 (261)

Concluding Remarks for Special Issue HTLV-HIV Co-Infections

open access: yesViruses, 2023
During the early 1980s, the first 3 human retroviruses were identified: human T-lymphotropic virus 1 and 2 (HTLV-1 and HTLV-2) and human immunodeficiency virus (HIV) [...]
Alejandro Vallejo   +1 more
doaj   +1 more source

Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence. [PDF]

open access: yes, 2011
Due to unacceptably high mortality with pentavalent antimonials, Médecins Sans Frontières in 2006 began using liposomal amphotericin B (AmBisome) for visceral leishmaniasis (VL) patients in Ethiopia who were severely ill or positive for human ...
Aderie, Endashaw Mengistu   +6 more
core   +2 more sources

Voluntary Counselling and Testing for HIV Among Allied Workers in Rural Area of Nigeria: Evaluation of Community-Based Interventions

open access: yesInternational Journal of Occupational Safety and Health, 2020
Introduction: Knowledge of human immunodeficiency virus status is a key tool in the fight against the spread of the human immunodeficiency virus epidemic.
Ali Johnson Onoja   +6 more
doaj   +3 more sources

Seroprevalence and trend of human immunodeficiency virus among blood donors in Ethiopia: a systematic review and meta-analysis

open access: yesBMC Infectious Diseases, 2019
Background Blood transfusion is one of the routine therapeutic interventions in hospitals that can be lifesaving. However, this intervention is related to several transfusion-related infections.
Henok Mulugeta   +5 more
doaj   +1 more source

Feasibility of using teleradiology to improve tuberculosis screening and case management in a district hospital in Malawi. [PDF]

open access: yes, 2012
Malawi has one of the world's highest rates of human immunodeficiency virus (HIV) infection (10.6%), and southern Malawi, where Thyolo district is located, bears the highest burden in the country (14.5%).
Brant, W E   +6 more
core   +2 more sources

Chimpanzee reservoirs of pandemic and nonpandemic HIV-1 [PDF]

open access: yes, 2006
Human immunodeficiency virus type 1 (HIV-1), the cause of human acquired immunodeficiency syndrome ( AIDS), is a zoonotic infection of staggering proportions and social impact. Yet uncertainty persists regarding its natural reservoir.
Bailes, Elizabeth   +18 more
core   +1 more source

Assessment of the Potential Impact and Cost-effectiveness of Self-Testing for HIV in Low-Income Countries. [PDF]

open access: yes, 2015
Studies have demonstrated that self-testing for human immunodeficiency virus (HIV) is highly acceptable among individuals and could allow cost savings, compared with provider-delivered HIV testing and counseling (PHTC), although the longer-term ...
Cambiano, V   +8 more
core   +1 more source

Human immunodeficiency virus (HIV) in older people [PDF]

open access: yesAge and Ageing, 2010
The number of older people living with human immunodeficiency virus (HIV) in the UK is rising. Older people are at risk of acquiring HIV infection for a multitude of reasons. This, combined with effective HIV treatment which has significantly prolonged life expectancy, means that health care professionals working in the UK can expect to see increasing ...
Katherine Cunningham   +3 more
openaire   +3 more sources

Moderate restriction of macrophage-tropic human immunodeficiency virus type 1 by SAMHD1 in monocyte-derived macrophages.

open access: yesPLoS ONE, 2014
Macrophage-tropic human immunodeficiency virus type 1 (HIV-1) strains are able to grow to high titers in human monocyte-derived macrophages. However, it was recently reported that cellular protein SAMHD1 restricts HIV-1 replication in human cells of the ...
Kahoru Taya   +2 more
doaj   +1 more source

Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. [PDF]

open access: yes, 2011
Tuberculosis remains an important cause of death among patients infected with the human immunodeficiency virus (HIV). Robust data are lacking with regard to the timing for the initiation of antiretroviral therapy (ART) in relation to the start of ...
Anne E. Goldfeld   +25 more
core   +3 more sources

Home - About - Disclaimer - Privacy